AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
HIGH-DOSE THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN PARTIAL-RESPONSE AFTER FIRST-LINE INDUCTION THERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
Authors: HAIOUN C LEPAGE E GISSELBRECHT C COIFFIER B DOYEN C MOREL P ATTAL M TILLY H DECONINCK E GAULARD P REYES F
Citation: C. Haioun et al., HIGH-DOSE THERAPY FOLLOWED BY STEM-CELL TRANSPLANTATION IN PARTIAL-RESPONSE AFTER FIRST-LINE INDUCTION THERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA, Annals of oncology, 9, 1998, pp. 5-8
PRIMARY CUTANEOUS LARGE-CELL LYMPHOMA - ANALYSIS OF 49 PATIENTS INCLUDED IN THE LNH87 PROSPECTIVE TRIAL OF POLYCHEMOTHERAPY FOR HIGH-GRADE LYMPHOMAS
Authors: BRICE P CAZALS D MOUNIER N VEROLA O NEIDHARTBERARD AM REMENIERAS L DECONINCK E DOYEN C HAMELSAND J MOLINA T MOULONGUET I GISSELBRECHT C
Citation: P. Brice et al., PRIMARY CUTANEOUS LARGE-CELL LYMPHOMA - ANALYSIS OF 49 PATIENTS INCLUDED IN THE LNH87 PROSPECTIVE TRIAL OF POLYCHEMOTHERAPY FOR HIGH-GRADE LYMPHOMAS, Leukemia, 12(2), 1998, pp. 213-219
ACTIVITY OF FLUDARABINE IN PREVIOUSLY TREATED WALDENSTROMS-MACROGLOBULINEMIA - A REPORT OF 71 CASES
Authors: LEBLOND V BENOTHMAN T DECONINCK E TAKSIN AL HAROUSSEAU JL DELGADO MA DELMER A MALOISEL F MARIETTE X MOREL P CLAUVEL JP DUBOISSET P ENTEZAM S HERMINE O MERLET M YAKOUBAGHA I GUIBON O CASPARD H FORT N
Citation: V. Leblond et al., ACTIVITY OF FLUDARABINE IN PREVIOUSLY TREATED WALDENSTROMS-MACROGLOBULINEMIA - A REPORT OF 71 CASES, Journal of clinical oncology, 16(6), 1998, pp. 2060-2064
PROLONGED REMISSION AND AUTOLOGOUS RECOVERY IN 2 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA AFTER GRAFT FAILURE OF ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: FOUILLARD L DECONINCK E TIBERGHIEN P DESCHASEAUX ML SOLARY E MUGNERET F BRION A HERVE P CAHN JY
Citation: L. Fouillard et al., PROLONGED REMISSION AND AUTOLOGOUS RECOVERY IN 2 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA AFTER GRAFT FAILURE OF ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21(9), 1998, pp. 943-946
MAINTENANCE THERAPY WITH ITERATIVE INJECTIONS OF ALLOGENEIC DONOR LYMPHOCYTES INTERFERON AFTER BMT IN ONE CASE POLYCYTHEMIA-VERA
Authors: DECONINCK E DESCHASEAUX M BRION A RACADOT E FEST T CAHN JY
Citation: E. Deconinck et al., MAINTENANCE THERAPY WITH ITERATIVE INJECTIONS OF ALLOGENEIC DONOR LYMPHOCYTES INTERFERON AFTER BMT IN ONE CASE POLYCYTHEMIA-VERA, Bone marrow transplantation, 21, 1998, pp. 235-235
AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 94 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL
Authors: HAIOUN C LEPAGE E GISSELBRECHT C COIFFIER B DOYEN C MOREL P ARTAL M TILLY H DECONINCK E GAULARD P REYES F
Citation: C. Haioun et al., AUTOLOGOUS TRANSPLANTATION VERSUS CONVENTIONAL SALVAGE THERAPY IN AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) PARTIALLY RESPONDING TO FIRST LINECHEMOTHERAPY - A STUDY OF 94 PATIENTS ENROLLED IN THE LNH87-2 PROTOCOL, Bone marrow transplantation, 21, 1998, pp. 599-599
TREATMENT OF NHL WITH HIGH-DOSE CHEMOTHERAPY AND PBSCT IN LONG-TERM REMITTERS AFTER HODGKINS-DISEASE
Authors: BENABDESSELAM H DECONINCK E VOILLAT L BONTEMPS P ANGONIN R CAHN JY
Citation: H. Benabdesselam et al., TREATMENT OF NHL WITH HIGH-DOSE CHEMOTHERAPY AND PBSCT IN LONG-TERM REMITTERS AFTER HODGKINS-DISEASE, British Journal of Haematology, 102(1), 1998, pp. 235-235
SEQUENTIAL HIGH-DOSE THERAPY (HDT) FOR HIGH-RISK (HR) INTERMEDIATE AND HIGH-GRADE ADULT PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) - A PILOT-STUDY OF GEOLAMS GROUP
Authors: MILPIED N DELWAIL V SENSEBE L IFRAH N CASASSUS P COLOMBAT P DECONINCK E LAMY T MOREAU P HAROUSSEAU JL
Citation: N. Milpied et al., SEQUENTIAL HIGH-DOSE THERAPY (HDT) FOR HIGH-RISK (HR) INTERMEDIATE AND HIGH-GRADE ADULT PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) - A PILOT-STUDY OF GEOLAMS GROUP, British Journal of Haematology, 102(1), 1998, pp. 236-237
FRONTLINE HIGH-DOSE THERAPY (HDT) WITH AUTOLOGOUS STEM-CELL SUPPORT (ASCT) IN YOUNG PTS WITH DISSEMINATED INTERMEDIATE OR HIGH-GRADE LYMPHOMAS - EVALUATION OF FEASIBILITY AND EFFICACY IN CONSECUTIVE PROSPECTIVE TRIALS
Authors: MILPIED N LAMY T DECONINCK E COLOMBAT P DELWAIL V DESABLENS B FOUSSARD C HAROUSSEAU JL
Citation: N. Milpied et al., FRONTLINE HIGH-DOSE THERAPY (HDT) WITH AUTOLOGOUS STEM-CELL SUPPORT (ASCT) IN YOUNG PTS WITH DISSEMINATED INTERMEDIATE OR HIGH-GRADE LYMPHOMAS - EVALUATION OF FEASIBILITY AND EFFICACY IN CONSECUTIVE PROSPECTIVE TRIALS, British Journal of Haematology, 102(1), 1998, pp. 237-237
THERAPEUTIC EXPERIENCES OF 21 PATIENTS WITH POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PT-LPD)
Authors: MILPIED N LAMY T DECONINCK E COLOMBAT P DELWAIL V DESABLENS B FOUSSARD C HAROUSSEAU JL
Citation: N. Milpied et al., THERAPEUTIC EXPERIENCES OF 21 PATIENTS WITH POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PT-LPD), British Journal of Haematology, 102(1), 1998, pp. 237-237
USE OF DONOR T-LYMPHOCYTES EXPRESSING HERPES-SIMPLEX THYMIDINE KINASEIN ALLOGENEIC BONE-MARROW TRANSPLANTATION - A PHASE I-II STUDY
Authors: TIBERGHIEN P CAHN JY BRION A DECONINCK E RACADOT E HERVE P MILPIED N LIOURE B GLUCKMAN E BORDIGONI P JACOB W CHIANG YW MARCUS S REYNOLDS C LONGO D
Citation: P. Tiberghien et al., USE OF DONOR T-LYMPHOCYTES EXPRESSING HERPES-SIMPLEX THYMIDINE KINASEIN ALLOGENEIC BONE-MARROW TRANSPLANTATION - A PHASE I-II STUDY, Human gene therapy, 8(5), 1997, pp. 615-624
PLACEBO-CONTROLLED PHASE-III STUDY OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA - FACTORS INFLUENCING CHEMOTHERAPY ADMINISTRATION
Authors: GISSELBRECHT C HAIOUN C LEPAGE E BASTION Y TILLY H BOSLY A DUPRIEZ B MARIT G HERBRECHT R DECONINCK E MAROLLEAU JP YVER A DABOUZHARROUCHE F COIFFIER B REYES F
Citation: C. Gisselbrecht et al., PLACEBO-CONTROLLED PHASE-III STUDY OF LENOGRASTIM (GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) IN AGGRESSIVE NON-HODGKINS-LYMPHOMA - FACTORS INFLUENCING CHEMOTHERAPY ADMINISTRATION, Leukemia & lymphoma, 25(3-4), 1997, pp. 289-300
IS THE INTERNATIONAL PROGNOSTIC INDEX FOR AGGRESSIVE LYMPHOMAS USEFULFOR LOW-GRADE LYMPHOMA PATIENTS - APPLICABILITY TO STAGE III-IV PATIENTS
Authors: FOUSSARD C DESABLENS B SENSEBE L FRANCOIS S MILPIED N DECONINCK E DELWAIL V DUGAY J LAMY T GHANDOUR C LEMEVEL A MAISONNEUVE H CASASSUS P COLOMBAT P
Citation: C. Foussard et al., IS THE INTERNATIONAL PROGNOSTIC INDEX FOR AGGRESSIVE LYMPHOMAS USEFULFOR LOW-GRADE LYMPHOMA PATIENTS - APPLICABILITY TO STAGE III-IV PATIENTS, Annals of oncology, 8, 1997, pp. 49-52
ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - DISEASE PRESENTATION, RESPONSE TO TREATMENT, AND SURVIVAL - A GROUPE DETUDE DES LYMPHOMES DE LADULTE STUDY ON 453 PATIENTS OLDER THAN 69 YEARS
Authors: BASTION YB BLAY JY DIVINE M BRICE P BORDESSOULE D SEBBAN C BLANC M TILLY T LEDERLIN P DECONINCK E SALLES B DUMONTET C BRIERE J COIFFIER B
Citation: Yb. Bastion et al., ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA - DISEASE PRESENTATION, RESPONSE TO TREATMENT, AND SURVIVAL - A GROUPE DETUDE DES LYMPHOMES DE LADULTE STUDY ON 453 PATIENTS OLDER THAN 69 YEARS, Journal of clinical oncology, 15(8), 1997, pp. 2945-2953
REFAIOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - CLINICAL AND BIOLOGICAL CHARACTERISTICS OF A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL
Authors: GAULARD P BELHADJ K TILLY H CHARLOTTE F LEBLOND V DUVAL C ANGONIN R DECONINCK E PEROT C PICO JL ZAFRANI ES FARCET JP REYES F
Citation: P. Gaulard et al., REFAIOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - CLINICAL AND BIOLOGICAL CHARACTERISTICS OF A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL, Experimental hematology, 25(8), 1997, pp. 386-386
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN)
Authors: DECONINCK E CAHN JY MILPIED N JOUET JP VERNANT JP ESPEROU H LIOURE B BORDIGONI P LEBLOND V TROUSSARD X CAILLOT D CORDONNIER JM HERVE P
Citation: E. Deconinck et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN), Bone marrow transplantation, 20(9), 1997, pp. 731-735
COST COMPARATIVE-STUDY OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND BONE-MARROW (ABM) TRANSPLANTATIONS FOR NON-HODGKINS-LYMPHOMA PATIENTS
Authors: WORONOFFLEMSI MC ARVEUX P LIMAT S DECONINCK E MOREL P CAHN JY
Citation: Mc. Woronofflemsi et al., COST COMPARATIVE-STUDY OF AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND BONE-MARROW (ABM) TRANSPLANTATIONS FOR NON-HODGKINS-LYMPHOMA PATIENTS, Bone marrow transplantation, 20(11), 1997, pp. 975-982
HEPATOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL
Authors: REYES F BELHADJ K TILLY H CHARLOTTE F LEBLOND V DUVAL C ANGONIN R DECONINCK E TULLIEZ M PEROT C PICO JL ZAFRANI ES FARCET JP GAULARD P
Citation: F. Reyes et al., HEPATOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - A RECENTLY RECOGNIZED ENTITY WHICH IS FATAL, Blood, 90(10), 1997, pp. 1508-1508
PROGNOSTIC FACTORS IN HIV-NEGATIVE PRIMARY CNS NHL - ANALYSIS FROM 135 PATIENTS TREATED BY THE LCP-88 TRIAL
Authors: DESABLENS B FRANCOIS S RODIER JM LEMEVEL A DELWAIL V SENSEBE L LEPRISE PY COLOMBAT P DECONINCK E BRIERE J HAROUSSEAU JL BAUDUER F LAMOUR C
Citation: B. Desablens et al., PROGNOSTIC FACTORS IN HIV-NEGATIVE PRIMARY CNS NHL - ANALYSIS FROM 135 PATIENTS TREATED BY THE LCP-88 TRIAL, Blood, 90(10), 1997, pp. 2609-2609
HIGH-DOSE DEXAMETHASONE THERAPY FOR RESISTANT AUTOIMMUNE THROMBOCYTOPENIC PURPURA
Authors: GODEAU B BIERLING P OKSENHENDLER E CASTAIGNE S DECONINCK E WECHSLER B
Citation: B. Godeau et al., HIGH-DOSE DEXAMETHASONE THERAPY FOR RESISTANT AUTOIMMUNE THROMBOCYTOPENIC PURPURA, American journal of hematology, 51(4), 1996, pp. 334-334
A RANDOMIZED TRIAL OF HYDROXYUREA VERSUS VP16 IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA
Authors: WATTEL E GUERCI A HECQUET B ECONOMOPOULOS T COPPLESTONE A MAHE B COUTEAUX ME RESEGOTTI L VOGLOVA V FOUSSARD C PEGOURIE B MICHAUX JJ DECONINCK E STOPPA AM MUFTI G OSCIER D FENAUX P
Citation: E. Wattel et al., A RANDOMIZED TRIAL OF HYDROXYUREA VERSUS VP16 IN ADULT CHRONIC MYELOMONOCYTIC LEUKEMIA, Blood, 88(7), 1996, pp. 2480-2487
SEQUENTIAL HIGH-DOSE THERAPY (HDT) FOR HIGH-RISK (HR) INTERMEDIATE AND HIGH-GRADE ADULT PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) - A PILOT-STUDY OF GOELAMS GROUP
Authors: MILPIED N DELWAIL V SENSEBE L IFRAH N CASASSUS P COLOMBAT P DECONINCK E LAMY T HAROUSSEAU JL
Citation: N. Milpied et al., SEQUENTIAL HIGH-DOSE THERAPY (HDT) FOR HIGH-RISK (HR) INTERMEDIATE AND HIGH-GRADE ADULT PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) - A PILOT-STUDY OF GOELAMS GROUP, Blood, 88(10), 1996, pp. 3867-3867
ADMINISTRATION OF DONOR T-CELLS EXPRESSING THE HERPES-SIMPLEX THYMIDINE-KINASE GENE IN CONJUNCTION WITH A T-CELL DEPLETED ALLOGENEIC MARROWGRAFT
Authors: TIBERGHIEN P CAHN JY MILLPIED N FERRAND C DECONINCK E BRION A REYNOLDS CW JACOB W CERTOUX JM CHIANG Y HERVE P
Citation: P. Tiberghien et al., ADMINISTRATION OF DONOR T-CELLS EXPRESSING THE HERPES-SIMPLEX THYMIDINE-KINASE GENE IN CONJUNCTION WITH A T-CELL DEPLETED ALLOGENEIC MARROWGRAFT, Blood, 88(10), 1996, pp. 1077-1077
LISTERIOSIS IN PATIENTS WITH MALIGNANT HE MOPATHY - A SERIES OF 3 CASES IN THE SAME WARD
Authors: FONTAN J BRION A DECONINCK E FLESCH M VUILLIER J ROZENBAUM A CSASZAR M DUPONT MJ MICHELBRIAND Y CAHN JY
Citation: J. Fontan et al., LISTERIOSIS IN PATIENTS WITH MALIGNANT HE MOPATHY - A SERIES OF 3 CASES IN THE SAME WARD, La Presse medicale, 24(1), 1995, pp. 23-25
PHOTOTHERAPY IN THE TREATMENT OF CUTANEOUS GRAFT-VERSUS-HOST DISEASE - OUR PRELIMINARY EXPERIENCE IN RESISTANT PATIENTS
Authors: AUBIN F BRION A DECONINCK E PLOUVIER E HERVE P HUMBERT P CAHN JY
Citation: F. Aubin et al., PHOTOTHERAPY IN THE TREATMENT OF CUTANEOUS GRAFT-VERSUS-HOST DISEASE - OUR PRELIMINARY EXPERIENCE IN RESISTANT PATIENTS, Transplantation, 59(1), 1995, pp. 151-155
Risultati: 1-25 | 26-37